NASDAQ: OFIX · Industrial Applications and Services · 4 alerts · CIK 884624
Share price
$6.80Close, Nov 16
Market cap
$277M
Shares outstanding
40.76MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Orthofix Medical Inc. filings on SEC EDGAR ↗
Orthofix Medical Insider Juniper Investment Company LLC Buys $5.11M of Stock
Juniper Investment Company LLC bought 689,803 shares of Orthofix Medical Inc. at $7.04 to $7.41 a share (average $7.40) in 2 transactions, worth $5.11M in total between Nov 9, 2026 and Nov 11, 2026. Shares held after the trade: 4,461,019 (+0.3%).
Orthofix reported a challenging Q3 2026, missing internal expectations due to US Spine market softness and supplier delays, leading to a downward revision of full-year revenue and EBITDA guidance.
Orthofix Medical Inc. reported net sales of $207.9 million for the third quarter of 2026, a slight increase from $205.6 million in the prior year period. The company achieved a quarterly operating income of $1.5 million, a significant improvement from the $17.0 million operating loss in Q3 2025, though it still recorded a net loss of $6.1 million for the quarter.
Orthofix Medical reported Q3 2026 net sales of $207.9 million, a 1% increase over the prior year, and a net loss of $6.1 million. The company revised its full-year 2026 revenue guidance downward to $825M-$830M to reflect weaker performance in its U.S. Spine business and ongoing efforts to improve commercial execution.
Term
Q3 2026
“Continued growth in Limb Reconstruction and Therapeutic Solutions helped offset weaker Spine performance. In U.S. Spine, we are accelerating actions to strengthen commercial execution, improve instrument set supply and allocation, and increase asset productivity by focusing resources on our highest-performing distributor partners, products and market opportunities.”
Massimo Calafiore, President and Chief Executive Officer